{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:20:03Z","timestamp":1794558003983,"version":"4.9.1"},"reference-count":307,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"8","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFF1201303"],"award-info":[{"award-number":["2021YFF1201303"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020AAA0109505"],"award-info":[{"award-number":["2020AAA0109505"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["YS2021YFF120009"],"award-info":[{"award-number":["YS2021YFF120009"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFF1201303"],"award-info":[{"award-number":["2021YFF1201303"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020AAA0109505"],"award-info":[{"award-number":["2020AAA0109505"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["YS2021YFF120009"],"award-info":[{"award-number":["YS2021YFF120009"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972196"],"award-info":[{"award-number":["81972196"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Commun"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p xml:lang=\"en\">Neutrophils are important components of the immune system and play a key role in defending against pathogenic infections and responding to inflammatory cues, including cancer. Their dysregulation indicates potential disease risk factors. However, their functional importance in disease progression has often been underestimated due to their short half\u2010life, especially as there is limited information on the role of intratumoral neutrophils. Recent studies on their prominent role in cancer have led to a paradigm shift in our understanding of the functional diversity of neutrophils. These studies highlight that neutrophils have emerged as key components of the tumor microenvironment, where they can play a dual role in promoting and suppressing cancer. Moreover, several approaches to therapeutically target neutrophils have emerged, and clinical trials are investigating their efficacy. In this review, we discussed the involvement of neutrophils in cancer initiation and progression. We summarized recent advances in therapeutic strategies targeting neutrophils and, most importantly, suggested future research directions that could facilitate the manipulation of neutrophils for therapeutic purposes in cancer patients.<\/jats:p>","DOI":"10.1002\/cac2.70027","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T03:39:24Z","timestamp":1745897964000},"page":"888-913","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Neutrophils in cancer: At the crucial crossroads of anti\u2010tumor and pro\u2010tumor"],"prefix":"10.34133","volume":"45","author":[{"given":"Wenpeng","family":"Cai","sequence":"first","affiliation":[{"name":"National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital","place":["Beijing, P. R. China"]},{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Fan","sequence":"additional","affiliation":[{"name":"National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital","place":["Beijing, P. R. China"]},{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2985-3440","authenticated-orcid":false,"given":"Chu","family":"Xiao","sequence":"additional","affiliation":[{"name":"National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital","place":["Beijing, P. R. China"]},{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqin","family":"Deng","sequence":"additional","affiliation":[{"name":"National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital","place":["Beijing, P. R. China"]},{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixiao","family":"Liu","sequence":"additional","affiliation":[{"name":"National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital","place":["Beijing, P. R. China"]},{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiang","family":"Li","sequence":"additional","affiliation":[{"name":"National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital","place":["Beijing, P. R. China"]},{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1884-5358","authenticated-orcid":false,"given":"Jie","family":"He","sequence":"additional","affiliation":[{"name":"National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital","place":["Beijing, P. R. China"]},{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, P. R. China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107753"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2016.01.043"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.02.016"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1205984","article-title":"Tumor\u2010resident memory T cells as a biomarker of the response to cancer immunotherapy","volume":"14","author":"Damei I","year":"2023","unstructured":"Damei I, Trickovic T, Mami\u2010Chouaib F, Corgnac S. Tumor\u2010resident memory T cells as a biomarker of the response to cancer immunotherapy. Front Immunol. 2023;14:1205984.","journal-title":"Front Immunol"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.08.043"},{"issue":"1","key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12943-023-01843-6","article-title":"The evolution and heterogeneity of neutrophils in cancers: origins, subsets, functions, orchestrations and clinical applications","volume":"22","author":"Liu S","year":"2023","unstructured":"Liu S, Wu W, Du Y, Yin H, Chen Q, Yu W, et\u00a0al. The evolution and heterogeneity of neutrophils in cancers: origins, subsets, functions, orchestrations and clinical applications. Mol Cancer. 2023;22((1)):148.","journal-title":"Mol Cancer"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2016.217"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0222-4"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098259"},{"issue":"9","key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.3390\/cancers16091626","article-title":"Predictive and Prognostic Relevance of Tumor\u2010Infiltrating Immune Cells: Tailoring Personalized Treatments against Different Cancer Types","volume":"16","author":"Dakal TC","year":"2024","unstructured":"Dakal TC, George N, Xu C, Suravajhala P, Kumar A. Predictive and Prognostic Relevance of Tumor\u2010Infiltrating Immune Cells: Tailoring Personalized Treatments against Different Cancer Types. Cancers (Basel). 2024;16((9)):1626.","journal-title":"Cancers (Basel)"},{"issue":"42","key":"e_1_3_2_12_2","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201801674","article-title":"Neutrophil\u2010Based Delivery Systems for Nanotherapeutics","volume":"14","author":"Han Y","year":"2018","unstructured":"Han Y, Zhao R, Xu F. Neutrophil\u2010Based Delivery Systems for Nanotherapeutics. Small. 2018;14((42)):e1801674.","journal-title":"Small"},{"issue":"5","key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of mice and not men: differences between mouse and human immunology","volume":"172","author":"Mestas J","year":"2004","unstructured":"Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol. 2004;172((5)):2731\u20138.","journal-title":"J Immunol"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.767175","article-title":"Neutrophils\u2010From Bone Marrow to First\u2010Line Defense of the Innate Immune System","volume":"12","author":"Kraus RF","year":"2021","unstructured":"Kraus RF, Gruber MA. Neutrophils\u2010From Bone Marrow to First\u2010Line Defense of the Innate Immune System. Front Immunol. 2021;12:767175.","journal-title":"Front Immunol"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fimmu.2017.00081","article-title":"Neutrophil Extracellular Traps and Its Implications in Inflammation: An Overview","volume":"8","author":"Delgado\u2010Rizo V","year":"2017","unstructured":"Delgado\u2010Rizo V, Martinez\u2010Guzman MA, Iniguez\u2010Gutierrez L, Garcia\u2010Orozco A, Alvarado\u2010Navarro A, Fafutis\u2010Morris M. Neutrophil Extracellular Traps and Its Implications in Inflammation: An Overview. Front Immunol. 2017;8:81.","journal-title":"Front Immunol"},{"issue":"12","key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"903","DOI":"10.20892\/j.issn.2095-3941.2024.0012","article-title":"Neutrophils in the era of single\u2010cell RNA sequencing: functions and targeted therapies in cancer","volume":"20","author":"Qin J","year":"2024","unstructured":"Qin J, Wei F, Ren X. Neutrophils in the era of single\u2010cell RNA sequencing: functions and targeted therapies in cancer. Cancer Biol Med. 2024;20((12)):903\u201314.","journal-title":"Cancer Biol Med"},{"issue":"8","key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.it.2010.05.006","article-title":"Neutrophil kinetics in health and disease","volume":"31","author":"Summers C","year":"2010","unstructured":"Summers C, Rankin SM, Condliffe AM, Singh N, Peters AM, Chilvers ER. Neutrophil kinetics in health and disease. Trends Immunol. 2010;31((8)):318\u201324.","journal-title":"Trends Immunol"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.adf6493"},{"issue":"4","key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1182\/blood-2010-01-259028","article-title":"In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5.4 days","volume":"116","author":"Pillay J","year":"2010","unstructured":"Pillay J, den Braber I, Vrisekoop N, Kwast LM, de Boer RJ, Borghans JA, et\u00a0al. In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5.4 days. Blood. 2010;116((4)):625\u20137.","journal-title":"Blood"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2021.101538"},{"issue":"3","key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ccr.2011.08.012","article-title":"Tumor entrained neutrophils inhibit seeding in the premetastatic lung","volume":"20","author":"Granot Z","year":"2011","unstructured":"Granot Z, Henke E, Comen EA, King TA, Norton L, Benezra R. Tumor entrained neutrophils inhibit seeding in the premetastatic lung. Cancer Cell. 2011;20((3)):300\u201314.","journal-title":"Cancer Cell"},{"issue":"1","key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1038\/s41467-020-18125-0","article-title":"Dual roles of neutrophils in metastatic colonization are governed by the host NK cell status","volume":"11","author":"Li P","year":"2020","unstructured":"Li P, Lu M, Shi J, Hua L, Gong Z, Li Q, et\u00a0al. Dual roles of neutrophils in metastatic colonization are governed by the host NK cell status. Nat Commun. 2020;11((1)):4387.","journal-title":"Nat Commun"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2013.02.003"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.3389\/fimmu.2020.01749","article-title":"The Emerging Role of Neutrophil Extracellular Traps (NETs) in Tumor Progression and Metastasis","volume":"11","author":"Masucci MT","year":"2020","unstructured":"Masucci MT, Minopoli M, Del Vecchio S, Carriero MV. The Emerging Role of Neutrophil Extracellular Traps (NETs) in Tumor Progression and Metastasis. Front Immunol. 2020;11:1749.","journal-title":"Front Immunol"},{"issue":"1","key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"e00057","DOI":"10.1128\/MMBR.00057-17","article-title":"The Ontogeny of a Neutrophil: Mechanisms of Granulopoiesis and Homeostasis","volume":"82","author":"Lawrence SM","year":"2018","unstructured":"Lawrence SM, Corriden R, Nizet V. The Ontogeny of a Neutrophil: Mechanisms of Granulopoiesis and Homeostasis. Microbiol Mol Biol Rev. 2018;82((1)):e00057\u201317.","journal-title":"Microbiol Mol Biol Rev"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.11.011"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12440"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/imr.13163"},{"issue":"4","key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood.V98.4.1226","article-title":"Role of the liver in regulating numbers of circulating neutrophils","volume":"98","author":"Shi J","year":"2001","unstructured":"Shi J, Gilbert GE, Kokubo Y, Ohashi T. Role of the liver in regulating numbers of circulating neutrophils. Blood. 2001;98((4)):1226\u201330.","journal-title":"Blood"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aau7148"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2007.06.002"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.2302\/kjm.60.47"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.10.026"},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2021.101515","article-title":"G\u2010CSF, the guardian of granulopoiesis","volume":"54","author":"Mehta HM","year":"2021","unstructured":"Mehta HM, Corey SJ. G\u2010CSF, the guardian of granulopoiesis. Semin Immunol. 2021;54:101515.","journal-title":"Semin Immunol"},{"issue":"23","key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"9499","DOI":"10.1073\/pnas.86.23.9499","article-title":"The kinetics of human granulopoiesis following treatment with granulocyte colony\u2010stimulating factor in vivo","volume":"86","author":"Lord BI","year":"1989","unstructured":"Lord BI, Bronchud MH, Owens S, Chang J, Howell A, Souza L, et\u00a0al. The kinetics of human granulopoiesis following treatment with granulocyte colony\u2010stimulating factor in vivo. Proc Natl Acad Sci U S A. 1989;86((23)):9499\u2013503.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2014.07.011"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2015.07.006"},{"issue":"4","key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/sj.leu.2400607","article-title":"Functional features of neutrophils induced by G\u2010CSF and GM\u2010CSF treatment: differential effects and clinical implications","volume":"11","author":"Spiekermann K","year":"1997","unstructured":"Spiekermann K, Roesler J, Emmendoerffer A, Elsner J, Welte K. Functional features of neutrophils induced by G\u2010CSF and GM\u2010CSF treatment: differential effects and clinical implications. Leukemia. 1997;11((4)):466\u201378.","journal-title":"Leukemia"},{"issue":"3","key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41435-020-0095-7","article-title":"Evolution and function of interleukin\u20104 receptor signaling in adaptive immunity and neutrophils","volume":"21","author":"Heeb LEM","year":"2020","unstructured":"Heeb LEM, Egholm C, Boyman O. Evolution and function of interleukin\u20104 receptor signaling in adaptive immunity and neutrophils. Genes Immun. 2020;21((3)):143\u20139.","journal-title":"Genes Immun"},{"issue":"11","key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"5882","DOI":"10.4049\/jimmunol.1201881","article-title":"IL\u20106 cooperates with G\u2010CSF to induce protumor function of neutrophils in bone marrow by enhancing STAT3 activation","volume":"190","author":"Yan B","year":"2013","unstructured":"Yan B, Wei JJ, Yuan Y, Sun R, Li D, Luo J, et\u00a0al. IL\u20106 cooperates with G\u2010CSF to induce protumor function of neutrophils in bone marrow by enhancing STAT3 activation. J Immunol. 2013;190((11)):5882\u201393.","journal-title":"J Immunol"},{"issue":"1","key":"e_1_3_2_41_2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13046-018-1003-0","article-title":"Tumor\u2010associated neutrophils induce EMT by IL\u201017a to promote migration and invasion in gastric cancer cells","volume":"38","author":"Li S","year":"2019","unstructured":"Li S, Cong X, Gao H, Lan X, Li Z, Wang W, et\u00a0al. Tumor\u2010associated neutrophils induce EMT by IL\u201017a to promote migration and invasion in gastric cancer cells. J Exp Clin Cancer Res. 2019;38((1)):6.","journal-title":"J Exp Clin Cancer Res"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00746-9"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.12.012"},{"issue":"7","key":"e_1_3_2_44_2","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1128\/IAI.72.7.3823-3828.2004","article-title":"In vivo interleukin\u20106 protects neutrophils from apoptosis in osteomyelitis","volume":"72","author":"Asensi V","year":"2004","unstructured":"Asensi V, Valle E, Meana A, Fierer J, Celada A, Alvarez V, et\u00a0al. In vivo interleukin\u20106 protects neutrophils from apoptosis in osteomyelitis. Infect Immun. 2004;72((7)):3823\u20138.","journal-title":"Infect Immun"},{"issue":"9","key":"e_1_3_2_45_2","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1182\/blood.V93.9.3096.409k09_3096_3105","article-title":"CCAAT\/enhancer binding protein epsilon is critical for effective neutrophil\u2010mediated response to inflammatory challenge","volume":"93","author":"Lekstrom\u2010Himes J","year":"1999","unstructured":"Lekstrom\u2010Himes J, Xanthopoulos KG. CCAAT\/enhancer binding protein epsilon is critical for effective neutrophil\u2010mediated response to inflammatory challenge. Blood. 1999;93((9)):3096\u2013105.","journal-title":"Blood"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2005.01.011"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-12-844605"},{"issue":"4","key":"e_1_3_2_48_2","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1074-7613(02)00424-7","article-title":"G\u2010CSF is an essential regulator of neutrophil trafficking from the bone marrow to the blood","volume":"17","author":"Semerad CL","year":"2002","unstructured":"Semerad CL, Liu F, Gregory AD, Stumpf K, Link DC. G\u2010CSF is an essential regulator of neutrophil trafficking from the bone marrow to the blood. Immunity. 2002;17((4)):413\u201323.","journal-title":"Immunity"},{"issue":"4","key":"e_1_3_2_49_2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000350282","article-title":"Regulation of circulating neutrophil numbers under homeostasis and in disease","volume":"5","author":"Strydom N","year":"2013","unstructured":"Strydom N, Rankin SM. Regulation of circulating neutrophil numbers under homeostasis and in disease. J Innate Immun. 2013;5((4)):304\u201314.","journal-title":"J Innate Immun"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1149"},{"issue":"19","key":"e_1_3_2_51_2","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1182\/blood-2008-09-177287","article-title":"CXCR4 is a key regulator of neutrophil release from the bone marrow under basal and stress granulopoiesis conditions","volume":"113","author":"Eash KJ","year":"2009","unstructured":"Eash KJ, Means JM, White DW, Link DC. CXCR4 is a key regulator of neutrophil release from the bone marrow under basal and stress granulopoiesis conditions. Blood. 2009;113((19)):4711\u20139.","journal-title":"Blood"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-09-308387"},{"issue":"2","key":"e_1_3_2_53_2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1182\/blood-2003-10-3638","article-title":"Role of the CXCR4\/SDF\u20101 chemokine axis in circulating neutrophil homeostasis","volume":"104","author":"Suratt BT","year":"2004","unstructured":"Suratt BT, Petty JM, Young SK, Malcolm KC, Lieber JG, Nick JA, et\u00a0al. Role of the CXCR4\/SDF\u20101 chemokine axis in circulating neutrophil homeostasis. Blood. 2004;104((2)):565\u201371.","journal-title":"Blood"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.04.040"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI41649"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2024.106705"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2003.02305.x"},{"issue":"1","key":"e_1_3_2_58_2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/(SICI)1097-0215(19960103)65:1<57::AID-IJC10>3.0.CO;2-F","article-title":"92 kDa type IV collagenase (MMP\u20109) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer","volume":"65","author":"Nielsen BS","year":"1996","unstructured":"Nielsen BS, Timshel S, Kjeldsen L, Sehested M, Pyke C, Borregaard N, et\u00a0al. 92 kDa type IV collagenase (MMP\u20109) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. Int J Cancer. 1996;65((1)):57\u201362.","journal-title":"Int J Cancer"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90337-9"},{"issue":"1","key":"e_1_3_2_60_2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/(SICI)1521-4141(199801)28:01<164::AID-IMMU164>3.0.CO;2-S","article-title":"Granulocyte chemotactic protein 2 acts via both IL\u20108 receptors, CXCR1 and CXCR2","volume":"28","author":"Wolf M","year":"1998","unstructured":"Wolf M, Delgado MB, Jones SA, Dewald B, Clark\u2010Lewis I, Baggiolini M. Granulocyte chemotactic protein 2 acts via both IL\u20108 receptors, CXCR1 and CXCR2. Eur J Immunol. 1998;28((1)):164\u201370.","journal-title":"Eur J Immunol"},{"issue":"3","key":"e_1_3_2_61_2","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1158\/2326-6066.CIR-22-0035","article-title":"Syntaphilin Regulates Neutrophil Migration in Cancer","volume":"11","author":"Fu S","year":"2023","unstructured":"Fu S, Deng H, Bertolini I, Perego M, Chen ES, Sanseviero E, et\u00a0al. Syntaphilin Regulates Neutrophil Migration in Cancer. Cancer Immunol Res. 2023;11((3)):278\u201389.","journal-title":"Cancer Immunol Res"},{"key":"e_1_3_2_62_2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fphys.2014.00114","article-title":"The role IL\u20101 in tumor\u2010mediated angiogenesis","volume":"5","author":"Voronov E","year":"2014","unstructured":"Voronov E, Carmi Y, Apte RN. The role IL\u20101 in tumor\u2010mediated angiogenesis. Front Physiol. 2014;5:114.","journal-title":"Front Physiol"},{"issue":"5","key":"e_1_3_2_63_2","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.4049\/jimmunol.150.5.1979","article-title":"Activation of tumor necrosis factor\u2010alpha production from human neutrophils by IL\u20102 via IL\u20102\u2010R beta","volume":"150","author":"Wei S","year":"1993","unstructured":"Wei S, Blanchard DK, Liu JH, Leonard WJ, Djeu JY. Activation of tumor necrosis factor\u2010alpha production from human neutrophils by IL\u20102 via IL\u20102\u2010R beta. J Immunol. 1993;150((5)):1979\u201387.","journal-title":"J Immunol"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI39065"},{"issue":"7556","key":"e_1_3_2_65_2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature14282","article-title":"IL\u201017\u2010producing gammadelta T cells and neutrophils conspire to promote breast cancer metastasis","volume":"522","author":"Coffelt SB","year":"2015","unstructured":"Coffelt SB, Kersten K, Doornebal CW, Weiden J, Vrijland K, Hau CS, et\u00a0al. IL\u201017\u2010producing gammadelta T cells and neutrophils conspire to promote breast cancer metastasis. Nature. 2015;522((7556)):345\u20138.","journal-title":"Nature"},{"key":"e_1_3_2_66_2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.667177","article-title":"CXCL8 Associated Dendritic Cell Activation Marker Expression and Recruitment as Indicators of Favorable Outcomes in Colorectal Cancer","volume":"12","author":"Li E","year":"2021","unstructured":"Li E, Yang X, Du Y, Wang G, Chan DW, Wu D, et\u00a0al. CXCL8 Associated Dendritic Cell Activation Marker Expression and Recruitment as Indicators of Favorable Outcomes in Colorectal Cancer. Front Immunol. 2021;12:667177.","journal-title":"Front Immunol"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20130440"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28551"},{"issue":"8","key":"e_1_3_2_69_2","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1182\/blood.V80.8.2012.2012","article-title":"Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products","volume":"80","author":"Colotta F","year":"1992","unstructured":"Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood. 1992;80((8)):2012\u201320.","journal-title":"Blood"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.108024"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri1200"},{"issue":"1","key":"e_1_3_2_72_2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jhep.2014.08.023","article-title":"Increased autophagy sustains the survival and pro\u2010tumourigenic effects of neutrophils in human hepatocellular carcinoma","volume":"62","author":"Li XF","year":"2015","unstructured":"Li XF, Chen DP, Ouyang FZ, Chen MM, Wu Y, Kuang DM, et\u00a0al. Increased autophagy sustains the survival and pro\u2010tumourigenic effects of neutrophils in human hepatocellular carcinoma. J Hepatol. 2015;62((1)):131\u20139.","journal-title":"J Hepatol"},{"issue":"3","key":"e_1_3_2_73_2","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ijc.28957","article-title":"Delayed apoptosis of tumor associated neutrophils in the absence of endogenous IFN\u2010beta","volume":"136","author":"Andzinski L","year":"2015","unstructured":"Andzinski L, Wu CF, Lienenklaus S, Kroger A, Weiss S, Jablonska J. Delayed apoptosis of tumor associated neutrophils in the absence of endogenous IFN\u2010beta. Int J Cancer. 2015;136((3)):572\u201383.","journal-title":"Int J Cancer"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1232221"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00532"},{"issue":"1","key":"e_1_3_2_76_2","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1038\/s41467-023-37515-8","article-title":"Smad3 is essential for polarization of tumor\u2010associated neutrophils in non\u2010small cell lung carcinoma","volume":"14","author":"Chung JY","year":"2023","unstructured":"Chung JY, Tang PC, Chan MK, Xue VW, Huang XR, Ng CS, et\u00a0al. Smad3 is essential for polarization of tumor\u2010associated neutrophils in non\u2010small cell lung carcinoma. Nat Commun. 2023;14((1)):1794.","journal-title":"Nat Commun"},{"issue":"3","key":"e_1_3_2_77_2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor\u2010associated neutrophil phenotype by TGF\u2010beta: \u201cN1\u201d versus \u201cN2\u201d TAN","volume":"16","author":"Fridlender ZG","year":"2009","unstructured":"Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L, et\u00a0al. Polarization of tumor\u2010associated neutrophil phenotype by TGF\u2010beta: \u201cN1\u201d versus \u201cN2\u201d TAN. Cancer Cell. 2009;16((3)):183\u201394.","journal-title":"Cancer Cell"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2019.04.012"},{"issue":"6","key":"e_1_3_2_79_2","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20220011","article-title":"Neutrophil phenotypes and functions in cancer: A consensus statement","volume":"219","author":"Quail DF","year":"2022","unstructured":"Quail DF, Amulic B, Aziz M, Barnes BJ, Eruslanov E, Fridlender ZG, et\u00a0al. Neutrophil phenotypes and functions in cancer: A consensus statement. J Exp Med. 2022;219((6)):e20220011.","journal-title":"J Exp Med"},{"issue":"8","key":"e_1_3_2_80_2","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nri2808","article-title":"The polarization of immune cells in the tumour environment by TGFbeta","volume":"10","author":"Flavell RA","year":"2010","unstructured":"Flavell RA, Sanjabi S, Wrzesinski SH, Licona\u2010Limon P. The polarization of immune cells in the tumour environment by TGFbeta. Nat Rev Immunol. 2010;10((8)):554\u201367.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"e_1_3_2_81_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031524","article-title":"Transcriptomic analysis comparing tumor\u2010associated neutrophils with granulocytic myeloid\u2010derived suppressor cells and normal neutrophils","volume":"7","author":"Fridlender ZG","year":"2012","unstructured":"Fridlender ZG, Sun J, Mishalian I, Singhal S, Cheng G, Kapoor V, et\u00a0al. Transcriptomic analysis comparing tumor\u2010associated neutrophils with granulocytic myeloid\u2010derived suppressor cells and normal neutrophils. PLoS One. 2012;7((2)):e31524.","journal-title":"PLoS One"},{"issue":"8","key":"e_1_3_2_82_2","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/ijc.29945","article-title":"Type I IFNs induce anti\u2010tumor polarization of tumor associated neutrophils in mice and human","volume":"138","author":"Andzinski L","year":"2016","unstructured":"Andzinski L, Kasnitz N, Stahnke S, Wu CF, Gereke M, von Kockritz\u2010Blickwede M, et\u00a0al. Type I IFNs induce anti\u2010tumor polarization of tumor associated neutrophils in mice and human. Int J Cancer. 2016;138((8)):1982\u201393.","journal-title":"Int J Cancer"},{"issue":"6","key":"e_1_3_2_83_2","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.263","article-title":"The IL\u20106\u2010STAT3 axis mediates a reciprocal crosstalk between cancer\u2010derived mesenchymal stem cells and neutrophils to synergistically prompt gastric cancer progression","volume":"5","author":"Zhu Q","year":"2014","unstructured":"Zhu Q, Zhang X, Zhang L, Li W, Wu H, Yuan X, et\u00a0al. The IL\u20106\u2010STAT3 axis mediates a reciprocal crosstalk between cancer\u2010derived mesenchymal stem cells and neutrophils to synergistically prompt gastric cancer progression. Cell Death Dis. 2014;5((6)):e1295.","journal-title":"Cell Death Dis"},{"issue":"1","key":"e_1_3_2_84_2","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1067744","article-title":"Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonist attenuate tumor growth via polarization of neutrophils toward an antitumor phenotype","volume":"5","author":"Shrestha S","year":"2016","unstructured":"Shrestha S, Noh JM, Kim SY, Ham HY, Kim YJ, Yun YJ, et\u00a0al. Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonist attenuate tumor growth via polarization of neutrophils toward an antitumor phenotype. Oncoimmunology. 2016;5((1)):e1067744.","journal-title":"Oncoimmunology"},{"issue":"1","key":"e_1_3_2_85_2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1172\/JCI130952","article-title":"Relief of tumor hypoxia unleashes the tumoricidal potential of neutrophils","volume":"130","author":"Mahiddine K","year":"2020","unstructured":"Mahiddine K, Blaisdell A, Ma S, Crequer\u2010Grandhomme A, Lowell CA, Erlebacher A. Relief of tumor hypoxia unleashes the tumoricidal potential of neutrophils. J Clin Invest. 2020;130((1)):389\u2013403.","journal-title":"J Clin Invest"},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-013-1286-4"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2013.02.008"},{"key":"e_1_3_2_88_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-326070"},{"key":"e_1_3_2_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107556"},{"issue":"10","key":"e_1_3_2_90_2","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1494113","article-title":"Prognostic role of pretreatment circulating MDSCs in patients with solid malignancies: A meta\u2010analysis of 40 studies","volume":"7","author":"Wang PF","year":"2018","unstructured":"Wang PF, Song SY, Wang TJ, Ji WJ, Li SW, Liu N, et\u00a0al. Prognostic role of pretreatment circulating MDSCs in patients with solid malignancies: A meta\u2010analysis of 40 studies. Oncoimmunology. 2018;7((10)):e1494113.","journal-title":"Oncoimmunology"},{"key":"e_1_3_2_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2018.03.009"},{"key":"e_1_3_2_92_2","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-16-0297"},{"issue":"8","key":"e_1_3_2_93_2","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s00262-012-1294-5","article-title":"Neutrophils and granulocytic myeloid\u2010derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology","volume":"61","author":"Dumitru CA","year":"2012","unstructured":"Dumitru CA, Moses K, Trellakis S, Lang S, Brandau S. Neutrophils and granulocytic myeloid\u2010derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology. Cancer Immunol Immunother. 2012;61((8)):1155\u201367.","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"e_1_3_2_94_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121546","article-title":"A method for identification and analysis of non\u2010overlapping myeloid immunophenotypes in humans","volume":"10","author":"Gustafson MP","year":"2015","unstructured":"Gustafson MP, Lin Y, Maas ML, Van Keulen VP, Johnston PB, Peikert T, et\u00a0al. A method for identification and analysis of non\u2010overlapping myeloid immunophenotypes in humans. PLoS One. 2015;10((3)):e0121546.","journal-title":"PLoS One"},{"key":"e_1_3_2_95_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aay6017"},{"key":"e_1_3_2_96_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.03.009"},{"issue":"4","key":"e_1_3_2_97_2","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201803","article-title":"Analysis of classical neutrophils and polymorphonuclear myeloid\u2010derived suppressor cells in cancer patients and tumor\u2010bearing mice","volume":"218","author":"Veglia F","year":"2021","unstructured":"Veglia F, Hashimoto A, Dweep H, Sanseviero E, De Leo A, Tcyganov E, et\u00a0al. Analysis of classical neutrophils and polymorphonuclear myeloid\u2010derived suppressor cells in cancer patients and tumor\u2010bearing mice. J Exp Med. 2021;218((4)):e20201803.","journal-title":"J Exp Med"},{"key":"e_1_3_2_98_2","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aaf8943"},{"key":"e_1_3_2_99_2","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12876"},{"issue":"9","key":"e_1_3_2_100_2","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.879","article-title":"Isolation of Mouse Neutrophils","volume":"3","author":"Wishart AL","year":"2023","unstructured":"Wishart AL, Swamydas M, Lionakis MS. Isolation of Mouse Neutrophils. Curr Protoc. 2023;3((9)):e879.","journal-title":"Curr Protoc"},{"key":"e_1_3_2_101_2","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1002\/0471142735.im0320s110","article-title":"Isolation of Mouse Neutrophils","volume":"110","author":"Swamydas M","year":"2015","unstructured":"Swamydas M, Luo Y, Dorf ME, Lionakis MS. Isolation of Mouse Neutrophils. Curr Protoc Immunol. 2015;110:3201\u2013315.","journal-title":"Curr Protoc Immunol"},{"issue":"4","key":"e_1_3_2_102_2","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.celrep.2014.12.039","article-title":"Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer","volume":"10","author":"Sagiv JY","year":"2015","unstructured":"Sagiv JY, Michaeli J, Assi S, Mishalian I, Kisos H, Levy L, et\u00a0al. Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer. Cell Rep. 2015;10((4)):562\u201373.","journal-title":"Cell Rep"},{"key":"e_1_3_2_103_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2019.05.091"},{"key":"e_1_3_2_104_2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/978-1-4939-3801-8_13","article-title":"Isolation and Characterization of Low\u2010 vs. High\u2010Density Neutrophils in Cancer","volume":"1458","author":"Sagiv JY","year":"2016","unstructured":"Sagiv JY, Voels S, Granot Z. Isolation and Characterization of Low\u2010 vs. High\u2010Density Neutrophils in Cancer. Methods Mol Biol. 2016;1458:179\u201393.","journal-title":"Methods Mol Biol"},{"key":"e_1_3_2_105_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.06.001"},{"key":"e_1_3_2_106_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.08.008"},{"key":"e_1_3_2_107_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-07-445189"},{"issue":"5","key":"e_1_3_2_108_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007073","article-title":"An unappreciated role for neutrophil\u2010DC hybrids in immunity to invasive fungal infections","volume":"14","author":"Fites JS","year":"2018","unstructured":"Fites JS, Gui M, Kernien JF, Negoro P, Dagher Z, Sykes DB, et\u00a0al. An unappreciated role for neutrophil\u2010DC hybrids in immunity to invasive fungal infections. PLoS Pathog. 2018;14((5)):e1007073.","journal-title":"PLoS Pathog"},{"issue":"10","key":"e_1_3_2_109_2","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1182\/blood-2012-07-445197","article-title":"Emergence, origin, and function of neutrophil\u2010dendritic cell hybrids in experimentally induced inflammatory lesions in mice","volume":"121","author":"Geng S","year":"2013","unstructured":"Geng S, Matsushima H, Okamoto T, Yao Y, Lu R, Page K, et\u00a0al. Emergence, origin, and function of neutrophil\u2010dendritic cell hybrids in experimentally induced inflammatory lesions in mice. Blood. 2013;121((10)):1690\u2013700.","journal-title":"Blood"},{"key":"e_1_3_2_110_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.187.7.1019"},{"issue":"1","key":"e_1_3_2_111_2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41392-024-01848-7","article-title":"Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets","volume":"9","author":"Zhang S","year":"2024","unstructured":"Zhang S, Xiao X, Yi Y, Wang X, Zhu L, Shen Y, et\u00a0al. Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets. Signal Transduct Target Ther. 2024;9((1)):149.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"e_1_3_2_112_2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0891-5849(98)00285-8","article-title":"Neutrophils cause oxidative DNA damage in alveolar epithelial cells","volume":"27","author":"Knaapen AM","year":"1999","unstructured":"Knaapen AM, Seiler F, Schilderman PA, Nehls P, Bruch J, Schins RP, et\u00a0al. Neutrophils cause oxidative DNA damage in alveolar epithelial cells. Free Radic Biol Med. 1999;27((1\u20102)):234\u201340.","journal-title":"Free Radic Biol Med"},{"key":"e_1_3_2_113_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101277"},{"key":"e_1_3_2_114_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI122085"},{"issue":"1","key":"e_1_3_2_115_2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1053\/j.gastro.2021.03.027","article-title":"Neutrophils Alter DNA Repair Landscape to Impact Survival and Shape Distinct Therapeutic Phenotypes of Colorectal Cancer","volume":"161","author":"Bui TM","year":"2021","unstructured":"Bui TM, Butin\u2010Israeli V, Wiesolek HL, Zhou M, Rehring JF, Wiesmuller L, et\u00a0al. Neutrophils Alter DNA Repair Landscape to Impact Survival and Shape Distinct Therapeutic Phenotypes of Colorectal Cancer. Gastroenterology. 2021;161((1)):225\u201338 e15.","journal-title":"Gastroenterology"},{"key":"e_1_3_2_116_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2007.141556"},{"issue":"1","key":"e_1_3_2_117_2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00917906","article-title":"Tumor cell lysis by activated human neutrophils: analysis of neutrophil\u2010delivered oxidative attack and role of leukocyte function\u2010associated antigen 1","volume":"15","author":"Dallegri F","year":"1991","unstructured":"Dallegri F, Ottonello L, Ballestrero A, Dapino P, Ferrando F, Patrone F, et\u00a0al. Tumor cell lysis by activated human neutrophils: analysis of neutrophil\u2010delivered oxidative attack and role of leukocyte function\u2010associated antigen 1. Inflammation. 1991;15((1)):15\u201330.","journal-title":"Inflammation"},{"issue":"4","key":"e_1_3_2_118_2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/mutage\/gel032","article-title":"Neutrophils and respiratory tract DNA damage and mutagenesis: a review","volume":"21","author":"Knaapen AM","year":"2006","unstructured":"Knaapen AM, Gungor N, Schins RP, Borm PJ, Van Schooten FJ. Neutrophils and respiratory tract DNA damage and mutagenesis: a review. Mutagenesis. 2006;21((4)):225\u201336.","journal-title":"Mutagenesis"},{"issue":"10","key":"e_1_3_2_119_2","doi-asserted-by":"crossref","DOI":"10.4161\/2162402X.2014.981995","article-title":"Transmissible inflammation\u2010induced colorectal cancer in inflammasome\u2010deficient mice","volume":"8","author":"Hu B","year":"2019","unstructured":"Hu B, Friedman G, Elinav E, Flavell RA. Transmissible inflammation\u2010induced colorectal cancer in inflammasome\u2010deficient mice. Oncoimmunology. 2019;8((10)):e981995.","journal-title":"Oncoimmunology"},{"key":"e_1_3_2_120_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0812347106"},{"key":"e_1_3_2_121_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI61067"},{"key":"e_1_3_2_122_2","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201490147"},{"issue":"6","key":"e_1_3_2_123_2","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jhep.2021.07.032","article-title":"Regulatory T\u2010cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non\u2010alcoholic steatohepatitis","volume":"75","author":"Wang H","year":"2021","unstructured":"Wang H, Zhang H, Wang Y, Brown ZJ, Xia Y, Huang Z, et\u00a0al. Regulatory T\u2010cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non\u2010alcoholic steatohepatitis. J Hepatol. 2021;75((6)):1271\u201383.","journal-title":"J Hepatol"},{"key":"e_1_3_2_124_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29914"},{"key":"e_1_3_2_125_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao4227"},{"key":"e_1_3_2_126_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aag1711"},{"key":"e_1_3_2_127_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-04-421040"},{"issue":"2","key":"e_1_3_2_128_2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nm.2084","article-title":"Neutrophil elastase\u2010mediated degradation of IRS\u20101 accelerates lung tumor growth","volume":"16","author":"Houghton AM","year":"2010","unstructured":"Houghton AM, Rzymkiewicz DM, Ji H, Gregory AD, Egea EE, Metz HE, et\u00a0al. Neutrophil elastase\u2010mediated degradation of IRS\u20101 accelerates lung tumor growth. Nat Med. 2010;16((2)):219\u201323.","journal-title":"Nat Med"},{"issue":"1","key":"e_1_3_2_129_2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1189\/jlb.72.1.167","article-title":"Human neutrophil defensins induce lung epithelial cell proliferation in vitro","volume":"72","author":"Aarbiou J","year":"2002","unstructured":"Aarbiou J, Ertmann M, van Wetering S, van Noort P, Rook D, Rabe KF, et\u00a0al. Human neutrophil defensins induce lung epithelial cell proliferation in vitro. J Leukoc Biol. 2002;72((1)):167\u201374.","journal-title":"J Leukoc Biol"},{"issue":"18","key":"e_1_3_2_130_2","doi-asserted-by":"crossref","first-page":"16471","DOI":"10.18632\/oncotarget.4106","article-title":"Neutrophils trigger a NF\u2010kappaB dependent polarization of tumor\u2010supportive stromal cells in germinal center B\u2010cell lymphomas","volume":"6","author":"Gregoire M","year":"2015","unstructured":"Gregoire M, Guilloton F, Pangault C, Mourcin F, Sok P, Latour M, et\u00a0al. Neutrophils trigger a NF\u2010kappaB dependent polarization of tumor\u2010supportive stromal cells in germinal center B\u2010cell lymphomas. Oncotarget. 2015;6((18)):16471\u201387.","journal-title":"Oncotarget"},{"issue":"7525","key":"e_1_3_2_131_2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nature13638","article-title":"Tumour\u2010infiltrating Gr\u20101+ myeloid cells antagonize senescence in cancer","volume":"515","author":"Di Mitri D","year":"2014","unstructured":"Di Mitri D, Toso A, Chen JJ, Sarti M, Pinton S, Jost TR, et\u00a0al. Tumour\u2010infiltrating Gr\u20101+ myeloid cells antagonize senescence in cancer. Nature. 2014;515((7525)):134\u20137.","journal-title":"Nature"},{"issue":"7","key":"e_1_3_2_132_2","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1053\/j.gastro.2016.02.040","article-title":"Tumor\u2010Associated Neutrophils Recruit Macrophages and T\u2010Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib","volume":"150","author":"Zhou SL","year":"2016","unstructured":"Zhou SL, Zhou ZJ, Hu ZQ, Huang XW, Wang Z, Chen EB, et\u00a0al. Tumor\u2010Associated Neutrophils Recruit Macrophages and T\u2010Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib. Gastroenterology. 2016;150((7)):1646\u201358 e17.","journal-title":"Gastroenterology"},{"issue":"11","key":"e_1_3_2_133_2","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1136\/gutjnl-2017-313923","article-title":"Neutrophils diminish T\u2010cell immunity to foster gastric cancer progression: the role of GM\u2010CSF\/PD\u2010L1\/PD\u20101 signalling pathway","volume":"66","author":"Zhang X","year":"2017","unstructured":"Zhang X, Xu W. Neutrophils diminish T\u2010cell immunity to foster gastric cancer progression: the role of GM\u2010CSF\/PD\u2010L1\/PD\u20101 signalling pathway. Gut. 2017;66((11)):1878\u201380.","journal-title":"Gut"},{"key":"e_1_3_2_134_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2017.04.017"},{"key":"e_1_3_2_135_2","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-17-0204"},{"key":"e_1_3_2_136_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-0800"},{"issue":"1","key":"e_1_3_2_137_2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.canlet.2015.07.027","article-title":"Infiltrating neutrophils promote renal cell carcinoma (RCC) proliferation via modulating androgen receptor (AR) \u2192 c\u2010Myc signals","volume":"368","author":"Song W","year":"2015","unstructured":"Song W, Li L, He D, Xie H, Chen J, Yeh CR, et\u00a0al. Infiltrating neutrophils promote renal cell carcinoma (RCC) proliferation via modulating androgen receptor (AR) \u2192 c\u2010Myc signals. Cancer Lett. 2015;368((1)):71\u20138.","journal-title":"Cancer Lett"},{"issue":"1","key":"e_1_3_2_138_2","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1038\/s41467-020-19193-y","article-title":"Neutrophil\u2010induced ferroptosis promotes tumor necrosis in glioblastoma progression","volume":"11","author":"Yee PP","year":"2020","unstructured":"Yee PP, Wei Y, Kim SY, Lu T, Chih SY, Lawson C, et\u00a0al. Neutrophil\u2010induced ferroptosis promotes tumor necrosis in glioblastoma progression. Nat Commun. 2020;11((1)):5424.","journal-title":"Nat Commun"},{"issue":"13","key":"e_1_3_2_139_2","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1038\/s44318-024-00130-4","article-title":"LC3\u2010associated phagocytosis of neutrophils triggers tumor ferroptotic cell death in glioblastoma","volume":"43","author":"Lu T","year":"2024","unstructured":"Lu T, Yee PP, Chih SY, Tang M, Chen H, Aregawi DG, et\u00a0al. LC3\u2010associated phagocytosis of neutrophils triggers tumor ferroptotic cell death in glioblastoma. EMBO J. 2024;43((13)):2582\u2013605.","journal-title":"EMBO J"},{"key":"e_1_3_2_140_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05443-0"},{"issue":"1","key":"e_1_3_2_141_2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1615\/CritRevOncog.v18.i1-2.40","article-title":"On the origin of cancer metastasis","volume":"18","author":"Seyfried TN","year":"2013","unstructured":"Seyfried TN, Huysentruyt LC. On the origin of cancer metastasis. Crit Rev Oncog. 2013;18((1\u20102)):43\u201373.","journal-title":"Crit Rev Oncog"},{"key":"e_1_3_2_142_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri3789"},{"issue":"4","key":"e_1_3_2_143_2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/jleuko\/qiad004","article-title":"Tumor\u2010activated neutrophils promote metastasis in breast cancer via the G\u2010CSF\u2010RLN2\u2010MMP\u20109 axis","volume":"113","author":"Sheng Y","year":"2023","unstructured":"Sheng Y, Peng W, Huang Y, Cheng L, Meng Y, Kwantwi LB, et\u00a0al. Tumor\u2010activated neutrophils promote metastasis in breast cancer via the G\u2010CSF\u2010RLN2\u2010MMP\u20109 axis. J Leukoc Biol. 2023;113((4)):383\u201399.","journal-title":"J Leukoc Biol"},{"issue":"8","key":"e_1_3_2_144_2","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1111\/cas.13286","article-title":"Insulin\u2010like growth factor\u20101 signaling is responsible for cathepsin G\u2010induced aggregation of breast cancer MCF\u20107 cells","volume":"108","author":"Morimoto\u2010Kamata R","year":"2017","unstructured":"Morimoto\u2010Kamata R, Yui S. Insulin\u2010like growth factor\u20101 signaling is responsible for cathepsin G\u2010induced aggregation of breast cancer MCF\u20107 cells. Cancer Sci. 2017;108((8)):1574\u201383.","journal-title":"Cancer Sci"},{"key":"e_1_3_2_145_2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2147\/JHC.S303588","article-title":"The Crosstalk Between Cancer Cells and Neutrophils Enhances Hepatocellular Carcinoma Metastasis via Neutrophil Extracellular Traps\u2010Associated Cathepsin G Component: A Potential Therapeutic Target","volume":"8","author":"Guan X","year":"2021","unstructured":"Guan X, Lu Y, Zhu H, Yu S, Zhao W, Chi X, et\u00a0al. The Crosstalk Between Cancer Cells and Neutrophils Enhances Hepatocellular Carcinoma Metastasis via Neutrophil Extracellular Traps\u2010Associated Cathepsin G Component: A Potential Therapeutic Target. J Hepatocell Carcinoma. 2021;8:451\u201365.","journal-title":"J Hepatocell Carcinoma"},{"key":"e_1_3_2_146_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2018.12.001"},{"issue":"1","key":"e_1_3_2_147_2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","article-title":"The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis","volume":"15","author":"Huang Y","year":"2022","unstructured":"Huang Y, Hong W, Wei X. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. J Hematol Oncol. 2022;15((1)):129.","journal-title":"J Hematol Oncol"},{"issue":"6","key":"e_1_3_2_148_2","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","article-title":"The basics of epithelial\u2010mesenchymal transition","volume":"119","author":"Kalluri R","year":"2009","unstructured":"Kalluri R, Weinberg RA. The basics of epithelial\u2010mesenchymal transition. J Clin Invest. 2009;119((6)):1420\u20138.","journal-title":"J Clin Invest"},{"issue":"6","key":"e_1_3_2_149_2","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1158\/1078-0432.CCR-18-2544","article-title":"Tumor\u2010Contacted Neutrophils Promote Metastasis by a CD90\u2010TIMP\u20101 Juxtacrine\u2010Paracrine Loop","volume":"25","author":"Wang Y","year":"2019","unstructured":"Wang Y, Chen J, Yang L, Li J, Wu W, Huang M, et\u00a0al. Tumor\u2010Contacted Neutrophils Promote Metastasis by a CD90\u2010TIMP\u20101 Juxtacrine\u2010Paracrine Loop. Clin Cancer Res. 2019;25((6)):1957\u201369.","journal-title":"Clin Cancer Res"},{"key":"e_1_3_2_150_2","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.812044","article-title":"Neutrophils Promote Tumor Progression in Oral Squamous Cell Carcinoma by Regulating EMT and JAK2\/STAT3 Signaling Through Chemerin","volume":"12","author":"Hu X","year":"2022","unstructured":"Hu X, Xiang F, Feng Y, Gao F, Ge S, Wang C, et\u00a0al. Neutrophils Promote Tumor Progression in Oral Squamous Cell Carcinoma by Regulating EMT and JAK2\/STAT3 Signaling Through Chemerin. Front Oncol. 2022;12:812044.","journal-title":"Front Oncol"},{"issue":"1","key":"e_1_3_2_151_2","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41467-022-28492-5","article-title":"Neutrophil extracellular traps promote metastasis in gastric cancer patients with postoperative abdominal infectious complications","volume":"13","author":"Xia X","year":"2022","unstructured":"Xia X, Zhang Z, Zhu C, Ni B, Wang S, Yang S, et\u00a0al. Neutrophil extracellular traps promote metastasis in gastric cancer patients with postoperative abdominal infectious complications. Nat Commun. 2022;13((1)):1017.","journal-title":"Nat Commun"},{"key":"e_1_3_2_152_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00238.2015"},{"key":"e_1_3_2_153_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7673"},{"key":"e_1_3_2_154_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature17038"},{"key":"e_1_3_2_155_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.11.037"},{"key":"e_1_3_2_156_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-0915-y"},{"key":"e_1_3_2_157_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.07.013"},{"key":"e_1_3_2_158_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0221-x"},{"key":"e_1_3_2_159_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2020.10.015"},{"issue":"6","key":"e_1_3_2_160_2","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1158\/2159-8290.CD-15-1157","article-title":"Neutrophils Suppress Intraluminal NK Cell\u2010Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells","volume":"6","author":"Spiegel A","year":"2016","unstructured":"Spiegel A, Brooks MW, Houshyar S, Reinhardt F, Ardolino M, Fessler E, et\u00a0al. Neutrophils Suppress Intraluminal NK Cell\u2010Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells. Cancer Discov. 2016;6((6)):630\u201349.","journal-title":"Cancer Discov"},{"issue":"1","key":"e_1_3_2_161_2","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/s41467-022-28438-x","article-title":"Lin28B\u2010high breast cancer cells promote immune suppression in the lung pre\u2010metastatic niche via exosomes and support cancer progression","volume":"13","author":"Qi M","year":"2022","unstructured":"Qi M, Xia Y, Wu Y, Zhang Z, Wang X, Lu L, et\u00a0al. Lin28B\u2010high breast cancer cells promote immune suppression in the lung pre\u2010metastatic niche via exosomes and support cancer progression. Nat Commun. 2022;13((1)):897.","journal-title":"Nat Commun"},{"key":"e_1_3_2_162_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27378"},{"key":"e_1_3_2_163_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0081-8"},{"key":"e_1_3_2_164_2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-3-030-73119-9_5","article-title":"Pre\u2010metastatic Niche Formation by Neutrophils in Different Organs","volume":"1329","author":"Siakaeva E","year":"2021","unstructured":"Siakaeva E, Jablonska J. Pre\u2010metastatic Niche Formation by Neutrophils in Different Organs. Adv Exp Med Biol. 2021;1329:93\u2013108.","journal-title":"Adv Exp Med Biol"},{"key":"e_1_3_2_165_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2018.12.004"},{"key":"e_1_3_2_166_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0601807103"},{"key":"e_1_3_2_167_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2613.2009.00641.x"},{"issue":"1","key":"e_1_3_2_168_2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0015-0282(00)00555-0","article-title":"Neutrophils infiltrating the endometrium express vascular endothelial growth factor: potential role in endometrial angiogenesis","volume":"74","author":"Mueller MD","year":"2000","unstructured":"Mueller MD, Lebovic DI, Garrett E, Taylor RN. Neutrophils infiltrating the endometrium express vascular endothelial growth factor: potential role in endometrial angiogenesis. Fertil Steril. 2000;74((1)):107\u201312.","journal-title":"Fertil Steril"},{"issue":"22","key":"e_1_3_2_169_2","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1182\/blood-2012-11-466532","article-title":"Neutrophils contribute to inflammatory lymphangiogenesis by increasing VEGF\u2010A bioavailability and secreting VEGF\u2010D","volume":"122","author":"Tan KW","year":"2013","unstructured":"Tan KW, Chong SZ, Wong FH, Evrard M, Tan SM, Keeble J, et\u00a0al. Neutrophils contribute to inflammatory lymphangiogenesis by increasing VEGF\u2010A bioavailability and secreting VEGF\u2010D. Blood. 2013;122((22)):3666\u201377.","journal-title":"Blood"},{"key":"e_1_3_2_170_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0712185105"},{"key":"e_1_3_2_171_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature06348"},{"issue":"13","key":"e_1_3_2_172_2","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.ejca.2008.06.031","article-title":"VEGF release by MMP\u20109 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis","volume":"44","author":"Hawinkels LJ","year":"2008","unstructured":"Hawinkels LJ, Zuidwijk K, Verspaget HW, de Jonge\u2010Muller ES, van Duijn W, Ferreira V, et\u00a0al. VEGF release by MMP\u20109 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis. Eur J Cancer. 2008;44((13)):1904\u201313.","journal-title":"Eur J Cancer"},{"issue":"9","key":"e_1_3_2_173_2","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1167\/iovs.06-1234","article-title":"Positive feedback regulation between MMP\u20109 and VEGF in human RPE cells","volume":"48","author":"Hollborn M","year":"2007","unstructured":"Hollborn M, Stathopoulos C, Steffen A, Wiedemann P, Kohen L, Bringmann A. Positive feedback regulation between MMP\u20109 and VEGF in human RPE cells. Invest Ophthalmol Vis Sci. 2007;48((9)):4360\u20137.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"e_1_3_2_174_2","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.neo.2014.08.013","article-title":"Tissue\u2010infiltrating neutrophils constitute the major in vivo source of angiogenesis\u2010inducing MMP\u20109 in the tumor microenvironment","volume":"16","author":"Deryugina EI","year":"2014","unstructured":"Deryugina EI, Zajac E, Juncker\u2010Jensen A, Kupriyanova TA, Welter L, Quigley JP. Tissue\u2010infiltrating neutrophils constitute the major in vivo source of angiogenesis\u2010inducing MMP\u20109 in the tumor microenvironment. Neoplasia. 2014;16((10)):771\u201388.","journal-title":"Neoplasia"},{"key":"e_1_3_2_175_2","doi-asserted-by":"publisher","DOI":"10.1038\/35036374"},{"issue":"2","key":"e_1_3_2_176_2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1096\/fj.01-0651fje","article-title":"Neutrophils as a key cellular target for angiostatin: implications for regulation of angiogenesis and inflammation","volume":"16","author":"Benelli R","year":"2002","unstructured":"Benelli R, Morini M, Carrozzino F, Ferrari N, Minghelli S, Santi L, et\u00a0al. Neutrophils as a key cellular target for angiostatin: implications for regulation of angiogenesis and inflammation. FASEB J. 2002;16((2)):267\u20139.","journal-title":"FASEB J"},{"issue":"25","key":"e_1_3_2_177_2","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1182\/blood-2013-05-501494","article-title":"Angiogenic capacity of M1\u2010 and M2\u2010polarized macrophages is determined by the levels of TIMP\u20101 complexed with their secreted proMMP\u20109","volume":"122","author":"Zajac E","year":"2013","unstructured":"Zajac E, Schweighofer B, Kupriyanova TA, Juncker\u2010Jensen A, Minder P, Quigley JP, et\u00a0al. Angiogenic capacity of M1\u2010 and M2\u2010polarized macrophages is determined by the levels of TIMP\u20101 complexed with their secreted proMMP\u20109. Blood. 2013;122((25)):4054\u201367.","journal-title":"Blood"},{"key":"e_1_3_2_178_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2004.09.022"},{"issue":"51","key":"e_1_3_2_179_2","doi-asserted-by":"crossref","first-page":"20262","DOI":"10.1073\/pnas.0706438104","article-title":"Human neutrophils uniquely release TIMP\u2010free MMP\u20109 to provide a potent catalytic stimulator of angiogenesis","volume":"104","author":"Ardi VC","year":"2007","unstructured":"Ardi VC, Kupriyanova TA, Deryugina EI, Quigley JP. Human neutrophils uniquely release TIMP\u2010free MMP\u20109 to provide a potent catalytic stimulator of angiogenesis. Proc Natl Acad Sci U S A. 2007;104((51)):20262\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"e_1_3_2_180_2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ccr.2013.10.009","article-title":"CXCR2\u2010expressing myeloid\u2010derived suppressor cells are essential to promote colitis\u2010associated tumorigenesis","volume":"24","author":"Katoh H","year":"2013","unstructured":"Katoh H, Wang D, Daikoku T, Sun H, Dey SK, Dubois RN. CXCR2\u2010expressing myeloid\u2010derived suppressor cells are essential to promote colitis\u2010associated tumorigenesis. Cancer Cell. 2013;24((5)):631\u201344.","journal-title":"Cancer Cell"},{"issue":"8","key":"e_1_3_2_181_2","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1182\/blood.V96.8.2673","article-title":"Neutrophil gelatinase B potentiates interleukin\u20108 tenfold by aminoterminal processing, whereas it degrades CTAP\u2010III, PF\u20104, and GRO\u2010alpha and leaves RANTES and MCP\u20102 intact","volume":"96","author":"Van den Steen PE","year":"2000","unstructured":"Van den Steen PE, Proost P, Wuyts A, Van Damme J, Opdenakker G. Neutrophil gelatinase B potentiates interleukin\u20108 tenfold by aminoterminal processing, whereas it degrades CTAP\u2010III, PF\u20104, and GRO\u2010alpha and leaves RANTES and MCP\u20102 intact. Blood. 2000;96((8)):2673\u201381.","journal-title":"Blood"},{"key":"e_1_3_2_182_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(00)00537-3"},{"key":"e_1_3_2_183_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0281-y"},{"key":"e_1_3_2_184_2","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1356965"},{"issue":"3","key":"e_1_3_2_185_2","first-page":"958s","article-title":"L\u2010Arginine regulates the expression of the T\u2010cell receptor zeta chain (CD3zeta) in Jurkat cells","volume":"7","author":"Taheri F","year":"2001","unstructured":"Taheri F, Ochoa JB, Faghiri Z, Culotta K, Park HJ, Lan MS, et\u00a0al. L\u2010Arginine regulates the expression of the T\u2010cell receptor zeta chain (CD3zeta) in Jurkat cells. Clin Cancer Res. 2001;7((3) Suppl):958s\u201365s.","journal-title":"Clin Cancer Res"},{"key":"e_1_3_2_186_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-0465"},{"issue":"11","key":"e_1_3_2_187_2","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ni1110-981","article-title":"A novel axis of innate immunity in cancer","volume":"11","author":"Mattarollo SR","year":"2010","unstructured":"Mattarollo SR, Smyth MJ. A novel axis of innate immunity in cancer. Nat Immunol. 2010;11((11)):981\u20132.","journal-title":"Nat Immunol"},{"issue":"4","key":"e_1_3_2_188_2","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1158\/0008-5472.CAN-08-1921","article-title":"Arginase I\u2010producing myeloid\u2010derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes","volume":"69","author":"Rodriguez PC","year":"2009","unstructured":"Rodriguez PC, Ernstoff MS, Hernandez C, Atkins M, Zabaleta J, Sierra R, et\u00a0al. Arginase I\u2010producing myeloid\u2010derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res. 2009;69((4)):1553\u201360.","journal-title":"Cancer Res"},{"key":"e_1_3_2_189_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.03.024"},{"issue":"6","key":"e_1_3_2_190_2","doi-asserted-by":"crossref","first-page":"E343","DOI":"10.1073\/pnas.1115635109","article-title":"Transforming growth factor beta\u2010activated kinase 1 (TAK1)\u2010dependent checkpoint in the survival of dendritic cells promotes immune homeostasis and function","volume":"109","author":"Wang Y","year":"2012","unstructured":"Wang Y, Huang G, Vogel P, Neale G, Reizis B, Chi H. Transforming growth factor beta\u2010activated kinase 1 (TAK1)\u2010dependent checkpoint in the survival of dendritic cells promotes immune homeostasis and function. Proc Natl Acad Sci U S A. 2012;109((6)):E343\u201352.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"e_1_3_2_191_2","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/sj.bjc.6602141","article-title":"Overexpression of TGF\u2010beta by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer","volume":"91","author":"Aoyagi Y","year":"2004","unstructured":"Aoyagi Y, Oda T, Kinoshita T, Nakahashi C, Hasebe T, Ohkohchi N, et\u00a0al. Overexpression of TGF\u2010beta by infiltrated granulocytes correlates with the expression of collagen mRNA in pancreatic cancer. Br J Cancer. 2004;91((7)):1316\u201326.","journal-title":"Br J Cancer"},{"key":"e_1_3_2_192_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1607"},{"issue":"1","key":"e_1_3_2_193_2","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13045-019-0699-4","article-title":"Tumor stem\u2010like cell\u2010derived exosomal RNAs prime neutrophils for facilitating tumorigenesis of colon cancer","volume":"12","author":"Hwang WL","year":"2019","unstructured":"Hwang WL, Lan HY, Cheng WC, Huang SC, Yang MH. Tumor stem\u2010like cell\u2010derived exosomal RNAs prime neutrophils for facilitating tumorigenesis of colon cancer. J Hematol Oncol. 2019;12((1)):10.","journal-title":"J Hematol Oncol"},{"key":"e_1_3_2_194_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-1177"},{"issue":"1","key":"e_1_3_2_195_2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41467-021-20982-2","article-title":"Stromal\u2010driven and Amyloid beta\u2010dependent induction of neutrophil extracellular traps modulates tumor growth","volume":"12","author":"Munir H","year":"2021","unstructured":"Munir H, Jones JO, Janowitz T, Hoffmann M, Euler M, Martins CP, et\u00a0al. Stromal\u2010driven and Amyloid beta\u2010dependent induction of neutrophil extracellular traps modulates tumor growth. Nat Commun. 2021;12((1)):683.","journal-title":"Nat Commun"},{"key":"e_1_3_2_196_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.10.005"},{"issue":"3","key":"e_1_3_2_197_2","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1158\/0008-5472.CAN-03-1808","article-title":"Neutrophil\u2010derived TNF\u2010related apoptosis\u2010inducing ligand (TRAIL): a novel mechanism of antitumor effect by neutrophils","volume":"64","author":"Koga Y","year":"2004","unstructured":"Koga Y, Matsuzaki A, Suminoe A, Hattori H, Hara T. Neutrophil\u2010derived TNF\u2010related apoptosis\u2010inducing ligand (TRAIL): a novel mechanism of antitumor effect by neutrophils. Cancer Res. 2004;64((3)):1037\u201343.","journal-title":"Cancer Res"},{"issue":"1","key":"e_1_3_2_198_2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4049\/jimmunol.149.1.113","article-title":"Granulocyte colony\u2010stimulating factor (G\u2010CSF) gene transduction in murine adenocarcinoma drives neutrophil\u2010mediated tumor inhibition in vivo. Neutrophils discriminate between G\u2010CSF\u2010producing and G\u2010CSF\u2010nonproducing tumor cells","volume":"149","author":"Colombo MP","year":"1992","unstructured":"Colombo MP, Lombardi L, Stoppacciaro A, Melani C, Parenza M, Bottazzi B, et\u00a0al. Granulocyte colony\u2010stimulating factor (G\u2010CSF) gene transduction in murine adenocarcinoma drives neutrophil\u2010mediated tumor inhibition in vivo. Neutrophils discriminate between G\u2010CSF\u2010producing and G\u2010CSF\u2010nonproducing tumor cells. J Immunol. 1992;149((1)):113\u20139.","journal-title":"J Immunol"},{"key":"e_1_3_2_199_2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.631821","article-title":"Neutrophils: Many Ways to Die","volume":"12","author":"Perez\u2010Figueroa E","year":"2021","unstructured":"Perez\u2010Figueroa E, Alvarez\u2010Carrasco P, Ortega E, Maldonado\u2010Bernal C. Neutrophils: Many Ways to Die. Front Immunol. 2021;12:631821.","journal-title":"Front Immunol"},{"key":"e_1_3_2_200_2","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.4MIR0220-574RR"},{"issue":"1","key":"e_1_3_2_201_2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1161\/01.RES.67.1.154","article-title":"Superoxide anion release from blood and bone marrow neutrophils is altered by endotoxemia","volume":"67","author":"Cerasoli F","year":"1990","unstructured":"Cerasoli F, Jr., McKenna PJ, Rosolia DL, Albertine KH, Peters SP, Gee MH. Superoxide anion release from blood and bone marrow neutrophils is altered by endotoxemia. Circ Res. 1990;67((1)):154\u201365.","journal-title":"Circ Res"},{"key":"e_1_3_2_202_2","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2012.5149"},{"key":"e_1_3_2_203_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.11.5798"},{"issue":"2","key":"e_1_3_2_204_2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00441-013-1753-0","article-title":"Angiostatin inhibits activation and migration of neutrophils","volume":"355","author":"Aulakh GK","year":"2014","unstructured":"Aulakh GK, Balachandran Y, Liu L, Singh B. Angiostatin inhibits activation and migration of neutrophils. Cell Tissue Res. 2014;355((2)):375\u201396.","journal-title":"Cell Tissue Res"},{"key":"e_1_3_2_205_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005743"},{"key":"e_1_3_2_206_2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9121488"},{"key":"e_1_3_2_207_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-016-5328-z"},{"key":"e_1_3_2_208_2","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.12818"},{"issue":"3","key":"e_1_3_2_209_2","first-page":"397","article-title":"The role of immunoglobulins in lymphocyte\u2010mediated cell damage, in vitro. I. Comparison of the effects of target cell specific antibody and normal serum factors on cellular damage by immune and non\u2010immune lymphocytes","volume":"18","author":"MacLennan IC","year":"1970","unstructured":"MacLennan IC, Loewi G, Harding B. The role of immunoglobulins in lymphocyte\u2010mediated cell damage, in vitro. I. Comparison of the effects of target cell specific antibody and normal serum factors on cellular damage by immune and non\u2010immune lymphocytes. Immunology. 1970;18((3)):397\u2013404.","journal-title":"Immunology"},{"issue":"3","key":"e_1_3_2_210_2","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1189\/jlb.0607366","article-title":"Eosinophils induce DC maturation, regulating immunity","volume":"83","author":"Lotfi R","year":"2008","unstructured":"Lotfi R, Lotze MT. Eosinophils induce DC maturation, regulating immunity. J Leukoc Biol. 2008;83((3)):456\u201360.","journal-title":"J Leukoc Biol"},{"key":"e_1_3_2_211_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102284"},{"key":"e_1_3_2_212_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.05.047"},{"issue":"12","key":"e_1_3_2_213_2","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1172\/JCI77053","article-title":"Tumor\u2010associated neutrophils stimulate T cell responses in early\u2010stage human lung cancer","volume":"124","author":"Eruslanov EB","year":"2014","unstructured":"Eruslanov EB, Bhojnagarwala PS, Quatromoni JG, Stephen TL, Ranganathan A, Deshpande C, et\u00a0al. Tumor\u2010associated neutrophils stimulate T cell responses in early\u2010stage human lung cancer. J Clin Invest. 2014;124((12)):5466\u201380.","journal-title":"J Clin Invest"},{"key":"e_1_3_2_214_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201343349"},{"key":"e_1_3_2_215_2","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1061175"},{"key":"e_1_3_2_216_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-2047"},{"issue":"9","key":"e_1_3_2_217_2","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/hepr.12436","article-title":"Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy","volume":"45","author":"Terashima T","year":"2015","unstructured":"Terashima T, Yamashita T, Iida N, Yamashita T, Nakagawa H, Arai K, et\u00a0al. Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy. Hepatol Res. 2015;45((9)):949\u201359.","journal-title":"Hepatol Res"},{"issue":"10","key":"e_1_3_2_218_2","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1038\/bjc.2014.163","article-title":"The elevated preoperative platelet\u2010to\u2010lymphocyte ratio predicts poor prognosis in breast cancer patients","volume":"110","author":"Krenn\u2010Pilko S","year":"2014","unstructured":"Krenn\u2010Pilko S, Langsenlehner U, Thurner EM, Stojakovic T, Pichler M, Gerger A, et\u00a0al. The elevated preoperative platelet\u2010to\u2010lymphocyte ratio predicts poor prognosis in breast cancer patients. Br J Cancer. 2014;110((10)):2524\u201330.","journal-title":"Br J Cancer"},{"issue":"6","key":"e_1_3_2_219_2","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/bjc.2016.23","article-title":"Derived neutrophil lymphocyte ratio is predictive of survival from intermittent therapy in advanced colorectal cancer: a post hoc analysis of the MRC COIN study","volume":"114","author":"Grenader T","year":"2016","unstructured":"Grenader T, Nash S, Adams R, Kaplan R, Fisher D, Maughan T, et\u00a0al. Derived neutrophil lymphocyte ratio is predictive of survival from intermittent therapy in advanced colorectal cancer: a post hoc analysis of the MRC COIN study. Br J Cancer. 2016;114((6)):612\u20135.","journal-title":"Br J Cancer"},{"issue":"6","key":"e_1_3_2_220_2","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju124","article-title":"Prognostic role of neutrophil\u2010to\u2010lymphocyte ratio in solid tumors: a systematic review and meta\u2010analysis","volume":"106","author":"Templeton AJ","year":"2014","unstructured":"Templeton AJ, McNamara MG, Seruga B, Vera\u2010Badillo FE, Aneja P, Ocana A, et\u00a0al. Prognostic role of neutrophil\u2010to\u2010lymphocyte ratio in solid tumors: a systematic review and meta\u2010analysis. J Natl Cancer Inst. 2014;106((6)):dju124.","journal-title":"J Natl Cancer Inst"},{"key":"e_1_3_2_221_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2017.05.005","article-title":"Prognostic role of pretreatment blood neutrophil\u2010to\u2010lymphocyte ratio in advanced cancer survivors: A systematic review and meta\u2010analysis of 66 cohort studies","volume":"58","author":"Mei Z","year":"2017","unstructured":"Mei Z, Shi L, Wang B, Yang J, Xiao Z, Du P, et\u00a0al. Prognostic role of pretreatment blood neutrophil\u2010to\u2010lymphocyte ratio in advanced cancer survivors: A systematic review and meta\u2010analysis of 66 cohort studies. Cancer Treat Rev. 2017;58:1\u201313.","journal-title":"Cancer Treat Rev"},{"issue":"5","key":"e_1_3_2_222_2","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/jso.24996","article-title":"Neutrophil: Lymphocyte ratio as a method of predicting complications following hepatic resection for colorectal liver metastasis","volume":"117","author":"McCluney SJ","year":"2018","unstructured":"McCluney SJ, Giakoustidis A, Segler A, Bissel J, Valente R, Hutchins RR, et\u00a0al. Neutrophil: Lymphocyte ratio as a method of predicting complications following hepatic resection for colorectal liver metastasis. J Surg Oncol. 2018;117((5)):1058\u201365.","journal-title":"J Surg Oncol"},{"issue":"3","key":"e_1_3_2_223_2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1055\/s-0034-1370765","article-title":"NETosis: a new factor in tumor progression and cancer\u2010associated thrombosis","volume":"40","author":"Demers M","year":"2014","unstructured":"Demers M, Wagner DD. NETosis: a new factor in tumor progression and cancer\u2010associated thrombosis. Semin Thromb Hemost. 2014;40((3)):277\u201383.","journal-title":"Semin Thromb Hemost"},{"key":"e_1_3_2_224_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3909"},{"key":"e_1_3_2_225_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.07.044"},{"issue":"6","key":"e_1_3_2_226_2","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/hep.25907","article-title":"Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma","volume":"56","author":"Zhou SL","year":"2012","unstructured":"Zhou SL, Dai Z, Zhou ZJ, Wang XY, Yang GH, Wang Z, et\u00a0al. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma. Hepatology. 2012;56((6)):2242\u201354.","journal-title":"Hepatology"},{"key":"e_1_3_2_227_2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13046-015-0256-0","article-title":"Peritumoural neutrophils negatively regulate adaptive immunity via the PD\u2010L1\/PD\u20101 signalling pathway in hepatocellular carcinoma","volume":"34","author":"He G","year":"2015","unstructured":"He G, Zhang H, Zhou J, Wang B, Chen Y, Kong Y, et\u00a0al. Peritumoural neutrophils negatively regulate adaptive immunity via the PD\u2010L1\/PD\u20101 signalling pathway in hepatocellular carcinoma. J Exp Clin Cancer Res. 2015;34:141.","journal-title":"J Exp Clin Cancer Res"},{"key":"e_1_3_2_228_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030806"},{"issue":"28","key":"e_1_3_2_229_2","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1200\/JCO.2008.18.9498","article-title":"Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma","volume":"27","author":"Jensen HK","year":"2009","unstructured":"Jensen HK, Donskov F, Marcussen N, Nordsmark M, Lundbeck F, von der Maase H. Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma. J Clin Oncol. 2009;27((28)):4709\u201317.","journal-title":"J Clin Oncol"},{"key":"e_1_3_2_230_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064814"},{"key":"e_1_3_2_231_2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.553967","article-title":"Tumor\u2010Associated Neutrophils and Macrophages\u2010Heterogenous but Not Chaotic","volume":"11","author":"Wu L","year":"2020","unstructured":"Wu L, Zhang XH. Tumor\u2010Associated Neutrophils and Macrophages\u2010Heterogenous but Not Chaotic. Front Immunol. 2020;11:553967.","journal-title":"Front Immunol"},{"key":"e_1_3_2_232_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2022.188762"},{"issue":"7","key":"e_1_3_2_233_2","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1158\/0008-5472.CAN-10-2583","article-title":"Tumor\u2010associated neutrophils: new targets for cancer therapy","volume":"71","author":"Gregory AD","year":"2011","unstructured":"Gregory AD, Houghton AM. Tumor\u2010associated neutrophils: new targets for cancer therapy. Cancer Res. 2011;71((7)):2411\u20136.","journal-title":"Cancer Res"},{"key":"e_1_3_2_234_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-4843"},{"issue":"2","key":"e_1_3_2_235_2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1189\/jlb.0504306","article-title":"Impaired interleukin\u20108\u2010 and GROalpha\u2010induced phosphorylation of extracellular signal\u2010regulated kinase result in decreased migration of neutrophils from patients with myelodysplasia","volume":"77","author":"Fuhler GM","year":"2005","unstructured":"Fuhler GM, Knol GJ, Drayer AL, Vellenga E. Impaired interleukin\u20108\u2010 and GROalpha\u2010induced phosphorylation of extracellular signal\u2010regulated kinase result in decreased migration of neutrophils from patients with myelodysplasia. J Leukoc Biol. 2005;77((2)):257\u201366.","journal-title":"J Leukoc Biol"},{"key":"e_1_3_2_236_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.03.001"},{"key":"e_1_3_2_237_2","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-313738"},{"key":"e_1_3_2_238_2","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.367"},{"issue":"4","key":"e_1_3_2_239_2","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1074-7613(03)00263-2","article-title":"Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence","volume":"19","author":"Martin C","year":"2003","unstructured":"Martin C, Burdon PC, Bridger G, Gutierrez\u2010Ramos JC, Williams TJ, Rankin SM. Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. Immunity. 2003;19((4)):583\u201393.","journal-title":"Immunity"},{"issue":"3","key":"e_1_3_2_240_2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jcf.2012.08.016","article-title":"Safety and early treatment effects of the CXCR2 antagonist SB\u2010656933 in patients with cystic fibrosis","volume":"12","author":"Moss RB","year":"2013","unstructured":"Moss RB, Mistry SJ, Konstan MW, Pilewski JM, Kerem E, Tal\u2010Singer R, et\u00a0al. Safety and early treatment effects of the CXCR2 antagonist SB\u2010656933 in patients with cystic fibrosis. J Cyst Fibros. 2013;12((3)):241\u20138.","journal-title":"J Cyst Fibros"},{"key":"e_1_3_2_241_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.04.014"},{"key":"e_1_3_2_242_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-2625"},{"issue":"2","key":"e_1_3_2_243_2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.canlet.2010.10.004","article-title":"Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases","volume":"300","author":"Varney ML","year":"2011","unstructured":"Varney ML, Singh S, Li A, Mayer\u2010Ezell R, Bond R, Singh RK. Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases. Cancer Lett. 2011;300((2)):180\u20138.","journal-title":"Cancer Lett"},{"issue":"11","key":"e_1_3_2_244_2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.medcli.2018.08.006","article-title":"A small\u2010molecule antagonist of CXCR1 and CXCR2 inhibits cell proliferation, migration and invasion in melanoma via PI3K\/AKT pathway","volume":"152","author":"Shang FM","year":"2019","unstructured":"Shang FM, Li J. A small\u2010molecule antagonist of CXCR1 and CXCR2 inhibits cell proliferation, migration and invasion in melanoma via PI3K\/AKT pathway. Med Clin (Barc). 2019;152((11)):425\u201330.","journal-title":"Med Clin (Barc)"},{"key":"e_1_3_2_245_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-2748"},{"issue":"2","key":"e_1_3_2_246_2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10549-021-06367-5","article-title":"A randomized, placebo\u2010controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front\u2010line therapy for metastatic triple\u2010negative breast cancer (fRida)","volume":"190","author":"Goldstein LJ","year":"2021","unstructured":"Goldstein LJ, Mansutti M, Levy C, Chang JC, Henry S, Fernandez\u2010Perez I, et\u00a0al. A randomized, placebo\u2010controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front\u2010line therapy for metastatic triple\u2010negative breast cancer (fRida). Breast Cancer Res Treat. 2021;190((2)):265\u201375.","journal-title":"Breast Cancer Res Treat"},{"key":"e_1_3_2_247_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-411638-2.00002-1"},{"key":"e_1_3_2_248_2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1085"},{"issue":"1","key":"e_1_3_2_249_2","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1038\/s41598-019-38643-2","article-title":"CXCR4 signaling regulates metastatic onset by controlling neutrophil motility and response to malignant cells","volume":"9","author":"Tulotta C","year":"2019","unstructured":"Tulotta C, Stefanescu C, Chen Q, Torraca V, Meijer AH, Snaar\u2010Jagalska BE. CXCR4 signaling regulates metastatic onset by controlling neutrophil motility and response to malignant cells. Sci Rep. 2019;9((1)):2399.","journal-title":"Sci Rep"},{"issue":"12","key":"e_1_3_2_250_2","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1158\/0008-5472.CAN-03-3958","article-title":"Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4","volume":"64","author":"Liang Z","year":"2004","unstructured":"Liang Z, Wu T, Lou H, Yu X, Taichman RS, Lau SK, et\u00a0al. Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res. 2004;64((12)):4302\u20138.","journal-title":"Cancer Res"},{"key":"e_1_3_2_251_2","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.284"},{"issue":"8","key":"e_1_3_2_252_2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1593\/neo.12324","article-title":"CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy","volume":"14","author":"Domanska UM","year":"2012","unstructured":"Domanska UM, Timmer\u2010Bosscha H, Nagengast WB, Oude Munnink TH, Kruizinga RC, Ananias HJ, et\u00a0al. CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy. Neoplasia. 2012;14((8)):709\u201318.","journal-title":"Neoplasia"},{"issue":"2","key":"e_1_3_2_253_2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1158\/1078-0432.CCR-12-2333","article-title":"BMS\u2010936564\/MDX\u20101338: a fully human anti\u2010CXCR4 antibody induces apoptosis in vitro and shows antitumor activity in vivo in hematologic malignancies","volume":"19","author":"Kuhne MR","year":"2013","unstructured":"Kuhne MR, Mulvey T, Belanger B, Chen S, Pan C, Chong C, et\u00a0al. BMS\u2010936564\/MDX\u20101338: a fully human anti\u2010CXCR4 antibody induces apoptosis in vitro and shows antitumor activity in vivo in hematologic malignancies. Clin Cancer Res. 2013;19((2)):357\u201366.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"e_1_3_2_254_2","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1158\/1078-0432.CCR-19-0647","article-title":"A Phase Ib\/II Trial of the First\u2010in\u2010Class Anti\u2010CXCR4 Antibody Ulocuplumab in Combination with Lenalidomide or Bortezomib Plus Dexamethasone in Relapsed Multiple Myeloma","volume":"26","author":"Ghobrial IM","year":"2020","unstructured":"Ghobrial IM, Liu CJ, Redd RA, Perez RP, Baz R, Zavidij O, et\u00a0al. A Phase Ib\/II Trial of the First\u2010in\u2010Class Anti\u2010CXCR4 Antibody Ulocuplumab in Combination with Lenalidomide or Bortezomib Plus Dexamethasone in Relapsed Multiple Myeloma. Clin Cancer Res. 2020;26((2)):344\u201353.","journal-title":"Clin Cancer Res"},{"key":"e_1_3_2_255_2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/bs.acr.2019.11.001","article-title":"The G protein coupled receptor CCR5 in cancer","volume":"145","author":"Upadhyaya C","year":"2020","unstructured":"Upadhyaya C, Jiao X, Ashton A, Patel K, Kossenkov AV, Pestell RG. The G protein coupled receptor CCR5 in cancer. Adv Cancer Res. 2020;145:29\u201347.","journal-title":"Adv Cancer Res"},{"key":"e_1_3_2_256_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2022.03.017"},{"issue":"5","key":"e_1_3_2_257_2","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.immuni.2020.04.011","article-title":"The CD47\u2010SIRPalpha Immune Checkpoint","volume":"52","author":"Logtenberg MEW","year":"2020","unstructured":"Logtenberg MEW, Scheeren FA, Schumacher TN. The CD47\u2010SIRPalpha Immune Checkpoint. Immunity. 2020;52((5)):742\u201352.","journal-title":"Immunity"},{"key":"e_1_3_2_258_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abp8309"},{"key":"e_1_3_2_259_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.02018"},{"key":"e_1_3_2_260_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137345"},{"issue":"1","key":"e_1_3_2_261_2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1189\/jlb.0407247","article-title":"Use of Ly6G\u2010specific monoclonal antibody to deplete neutrophils in mice","volume":"83","author":"Daley JM","year":"2008","unstructured":"Daley JM, Thomay AA, Connolly MD, Reichner JS, Albina JE. Use of Ly6G\u2010specific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol. 2008;83((1)):64\u201370.","journal-title":"J Leukoc Biol"},{"issue":"9","key":"e_1_3_2_262_2","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1002\/eji.201141979","article-title":"Revisiting the protective and pathogenic roles of neutrophils: Ly\u20106G is key","volume":"41","author":"Bao Y","year":"2011","unstructured":"Bao Y, Cao X. Revisiting the protective and pathogenic roles of neutrophils: Ly\u20106G is key! Eur J Immunol. 2011;41((9)):2535\u20138.","journal-title":"Eur J Immunol"},{"key":"e_1_3_2_263_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2008.02950.x"},{"key":"e_1_3_2_264_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2403"},{"key":"e_1_3_2_265_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.03.008"},{"issue":"11","key":"e_1_3_2_266_2","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007353","article-title":"Phase I\/Ib, open\u2010label, multicenter, dose\u2010escalation study of the anti\u2010TGF\u2010beta monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumors","volume":"11","author":"Bauer TM","year":"2023","unstructured":"Bauer TM, Santoro A, Lin CC, Garrido\u2010Laguna I, Joerger M, Greil R, et\u00a0al. Phase I\/Ib, open\u2010label, multicenter, dose\u2010escalation study of the anti\u2010TGF\u2010beta monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumors. J Immunother Cancer. 2023;11((11)):e007353.","journal-title":"J Immunother Cancer"},{"issue":"4","key":"e_1_3_2_267_2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00262-015-1653-0","article-title":"Cutaneous keratoacanthomas\/squamous cell carcinomas associated with neutralization of transforming growth factor beta by the monoclonal antibody fresolimumab (GC1008)","volume":"64","author":"Lacouture ME","year":"2015","unstructured":"Lacouture ME, Morris JC, Lawrence DP, Tan AR, Olencki TE, Shapiro GI, et\u00a0al. Cutaneous keratoacanthomas\/squamous cell carcinomas associated with neutralization of transforming growth factor beta by the monoclonal antibody fresolimumab (GC1008). Cancer Immunol Immunother. 2015;64((4)):437\u201346.","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"e_1_3_2_268_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090353","article-title":"Phase I study of GC1008 (fresolimumab): a human anti\u2010transforming growth factor\u2010beta (TGFbeta) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma","volume":"9","author":"Morris JC","year":"2014","unstructured":"Morris JC, Tan AR, Olencki TE, Shapiro GI, Dezube BJ, Reiss M, et\u00a0al. Phase I study of GC1008 (fresolimumab): a human anti\u2010transforming growth factor\u2010beta (TGFbeta) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma. PLoS One. 2014;9((3)):e90353.","journal-title":"PLoS One"},{"key":"e_1_3_2_269_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101623"},{"issue":"3","key":"e_1_3_2_270_2","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s10637-021-01207-1","article-title":"Radiosensitizing effect of galunisertib, a TGF\u2010ss receptor I inhibitor, on head and neck squamous cell carcinoma in vitro","volume":"40","author":"Jank BJ","year":"2022","unstructured":"Jank BJ, Lenz T, Haas M, Kadletz\u2010Wanke L, Campion NJ, Schnoell J, et\u00a0al. Radiosensitizing effect of galunisertib, a TGF\u2010ss receptor I inhibitor, on head and neck squamous cell carcinoma in vitro. Invest New Drugs. 2022;40((3)):478\u201386.","journal-title":"Invest New Drugs"},{"key":"e_1_3_2_271_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00446-6"},{"issue":"10","key":"e_1_3_2_272_2","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/s41416-018-0246-z","article-title":"Galunisertib plus gemcitabine vs. gemcitabine for first\u2010line treatment of patients with unresectable pancreatic cancer","volume":"119","author":"Melisi D","year":"2018","unstructured":"Melisi D, Garcia\u2010Carbonero R, Macarulla T, Pezet D, Deplanque G, Fuchs M, et\u00a0al. Galunisertib plus gemcitabine vs. gemcitabine for first\u2010line treatment of patients with unresectable pancreatic cancer. Br J Cancer. 2018;119((10)):1208\u201314.","journal-title":"Br J Cancer"},{"issue":"7","key":"e_1_3_2_273_2","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000056","article-title":"A Phase 2 Study of Galunisertib (TGF\u2010beta1 Receptor Type I Inhibitor) and Sorafenib in Patients With Advanced Hepatocellular Carcinoma","volume":"10","author":"Kelley RK","year":"2019","unstructured":"Kelley RK, Gane E, Assenat E, Siebler J, Galle PR, Merle P, et\u00a0al. A Phase 2 Study of Galunisertib (TGF\u2010beta1 Receptor Type I Inhibitor) and Sorafenib in Patients With Advanced Hepatocellular Carcinoma. Clin Transl Gastroenterol. 2019;10((7)):e00056.","journal-title":"Clin Transl Gastroenterol"},{"issue":"5","key":"e_1_3_2_274_2","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1007\/s10637-020-00910-9","article-title":"Phase 1b\/2a study of galunisertib, a small molecule inhibitor of transforming growth factor\u2010beta receptor I, in combination with standard temozolomide\u2010based radiochemotherapy in patients with newly diagnosed malignant glioma","volume":"38","author":"Wick A","year":"2020","unstructured":"Wick A, Desjardins A, Suarez C, Forsyth P, Gueorguieva I, Burkholder T, et\u00a0al. Phase 1b\/2a study of galunisertib, a small molecule inhibitor of transforming growth factor\u2010beta receptor I, in combination with standard temozolomide\u2010based radiochemotherapy in patients with newly diagnosed malignant glioma. Invest New Drugs. 2020;38((5)):1570\u20139.","journal-title":"Invest New Drugs"},{"issue":"3","key":"e_1_3_2_275_2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222259","article-title":"Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF\u2010betaRI inhibitor galunisertib","volume":"15","author":"Giannelli G","year":"2020","unstructured":"Giannelli G, Santoro A, Kelley RK, Gane E, Paradis V, Cleverly A, et\u00a0al. Biomarkers and overall survival in patients with advanced hepatocellular carcinoma treated with TGF\u2010betaRI inhibitor galunisertib. PLoS One. 2020;15((3)):e0222259.","journal-title":"PLoS One"},{"issue":"1","key":"e_1_3_2_276_2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13045-023-01442-4","article-title":"Myeloid\u2010like tumor hybrid cells in bone marrow promote progression of prostate cancer bone metastasis","volume":"16","author":"Ye X","year":"2023","unstructured":"Ye X, Huang X, Fu X, Zhang X, Lin R, Zhang W, et\u00a0al. Myeloid\u2010like tumor hybrid cells in bone marrow promote progression of prostate cancer bone metastasis. J Hematol Oncol. 2023;16((1)):46.","journal-title":"J Hematol Oncol"},{"issue":"2","key":"e_1_3_2_277_2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1158\/1535-7163.MCT-11-0289","article-title":"Identification of docetaxel resistance genes in castration\u2010resistant prostate cancer","volume":"11","author":"Marin\u2010Aguilera M","year":"2012","unstructured":"Marin\u2010Aguilera M, Codony\u2010Servat J, Kalko SG, Fernandez PL, Bermudo R, Buxo E, et\u00a0al. Identification of docetaxel resistance genes in castration\u2010resistant prostate cancer. Mol Cancer Ther. 2012;11((2)):329\u201339.","journal-title":"Mol Cancer Ther"},{"key":"e_1_3_2_278_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-12-823757"},{"key":"e_1_3_2_279_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2008.11.031"},{"key":"e_1_3_2_280_2","article-title":"An Engineered Arginase FC Protein Inhibits Tumor Growth In Vitro and In Vivo","volume":"2013","author":"Li L","year":"2013","unstructured":"Li L, Wang Y, Chen J, Cheng B, Hu J, Zhou Y, et\u00a0al. An Engineered Arginase FC Protein Inhibits Tumor Growth In Vitro and In Vivo. Evid Based Complement Alternat Med. 2013;2013:423129.","journal-title":"Evid Based Complement Alternat Med"},{"key":"e_1_3_2_281_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2019.12.005"},{"key":"e_1_3_2_282_2","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13871"},{"issue":"4","key":"e_1_3_2_283_2","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1200\/JCO.21.02508","article-title":"Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE\u2010048 Study","volume":"41","author":"Harrington KJ","year":"2023","unstructured":"Harrington KJ, Burtness B, Greil R, Soulieres D, Tahara M, de Castro G, Jr., et\u00a0al. Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE\u2010048 Study. J Clin Oncol. 2023;41((4)):790\u2013802.","journal-title":"J Clin Oncol"},{"issue":"8","key":"e_1_3_2_284_2","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.6980","article-title":"PD\u20101 inhibition with retifanlimab and\/or arginase inhibition with INCB001158 in Japanese patients with solid tumors: A phase I study","volume":"13","author":"Kuboki Y","year":"2024","unstructured":"Kuboki Y, Koyama T, Matsubara N, Naito Y, Kondo S, Harano K, et\u00a0al. PD\u20101 inhibition with retifanlimab and\/or arginase inhibition with INCB001158 in Japanese patients with solid tumors: A phase I study. Cancer Med. 2024;13((8)):e6980.","journal-title":"Cancer Med"},{"issue":"9","key":"e_1_3_2_285_2","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.4049\/jimmunol.1201654","article-title":"Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression","volume":"189","author":"Corrales L","year":"2012","unstructured":"Corrales L, Ajona D, Rafail S, Lasarte JJ, Riezu\u2010Boj JI, Lambris JD, et\u00a0al. Anaphylatoxin C5a creates a favorable microenvironment for lung cancer progression. J Immunol. 2012;189((9)):4674\u201383.","journal-title":"J Immunol"},{"issue":"7","key":"e_1_3_2_286_2","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1158\/2159-8290.CD-16-1184","article-title":"A Combined PD\u20101\/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis","volume":"7","author":"Ajona D","year":"2017","unstructured":"Ajona D, Ortiz\u2010Espinosa S, Moreno H, Lozano T, Pajares MJ, Agorreta J, et\u00a0al. A Combined PD\u20101\/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis. Cancer Discov. 2017;7((7)):694\u2013703.","journal-title":"Cancer Discov"},{"issue":"4","key":"e_1_3_2_287_2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ccell.2018.09.003","article-title":"Complement C5a Fosters Squamous Carcinogenesis and Limits T Cell Response to Chemotherapy","volume":"34","author":"Medler TR","year":"2018","unstructured":"Medler TR, Murugan D, Horton W, Kumar S, Cotechini T, Forsyth AM, et\u00a0al. Complement C5a Fosters Squamous Carcinogenesis and Limits T Cell Response to Chemotherapy. Cancer Cell. 2018;34((4)):561\u201378 e6.","journal-title":"Cancer Cell"},{"key":"e_1_3_2_288_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.01.021"},{"key":"e_1_3_2_289_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2008112117"},{"issue":"1","key":"e_1_3_2_290_2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1158\/1078-0432.CCR-13-1279","article-title":"Neutrophils promote the malignant glioma phenotype through S100A4","volume":"20","author":"Liang J","year":"2014","unstructured":"Liang J, Piao Y, Holmes L, Fuller GN, Henry V, Tiao N, et\u00a0al. Neutrophils promote the malignant glioma phenotype through S100A4. Clin Cancer Res. 2014;20((1)):187\u201398.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"e_1_3_2_291_2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.molmed.2014.10.009","article-title":"Human cancer immunotherapy with antibodies to the PD\u20101 and PD\u2010L1 pathway","volume":"21","author":"Ohaegbulam KC","year":"2015","unstructured":"Ohaegbulam KC, Assal A, Lazar\u2010Molnar E, Yao Y, Zang X. Human cancer immunotherapy with antibodies to the PD\u20101 and PD\u2010L1 pathway. Trends Mol Med. 2015;21((1)):24\u201333.","journal-title":"Trends Mol Med"},{"key":"e_1_3_2_292_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071860"},{"issue":"4","key":"e_1_3_2_293_2","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41419-018-0458-4","article-title":"Cancer\u2010associated fibroblasts induce PDL1+ neutrophils through the IL6\u2010STAT3 pathway that foster immune suppression in hepatocellular carcinoma","volume":"9","author":"Cheng Y","year":"2018","unstructured":"Cheng Y, Li H, Deng Y, Tai Y, Zeng K, Zhang Y, et\u00a0al. Cancer\u2010associated fibroblasts induce PDL1+ neutrophils through the IL6\u2010STAT3 pathway that foster immune suppression in hepatocellular carcinoma. Cell Death Dis. 2018;9((4)):422.","journal-title":"Cell Death Dis"},{"issue":"10","key":"e_1_3_2_294_2","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100825","article-title":"Tumor\u2010associated neutrophils suppress antitumor immunity of NK cells through the PD\u2010L1\/PD\u20101 axis","volume":"13","author":"Sun R","year":"2020","unstructured":"Sun R, Xiong Y, Liu H, Gao C, Su L, Weng J, et\u00a0al. Tumor\u2010associated neutrophils suppress antitumor immunity of NK cells through the PD\u2010L1\/PD\u20101 axis. Transl Oncol. 2020;13((10)):100825.","journal-title":"Transl Oncol"},{"issue":"1","key":"e_1_3_2_295_2","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1038\/s41467-021-23731-7","article-title":"Suppression of tumor\u2010associated neutrophils by lorlatinib attenuates pancreatic cancer growth and improves treatment with immune checkpoint blockade","volume":"12","author":"Nielsen SR","year":"2021","unstructured":"Nielsen SR, Strobech JE, Horton ER, Jackstadt R, Laitala A, Bravo MC, et\u00a0al. Suppression of tumor\u2010associated neutrophils by lorlatinib attenuates pancreatic cancer growth and improves treatment with immune checkpoint blockade. Nat Commun. 2021;12((1)):3414.","journal-title":"Nat Commun"},{"key":"e_1_3_2_296_2","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.2011.559457"},{"key":"e_1_3_2_297_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114827"},{"key":"e_1_3_2_298_2","doi-asserted-by":"publisher","DOI":"10.1038\/nnano.2017.54"},{"key":"e_1_3_2_299_2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/B978-0-12-802997-8.00023-2","article-title":"Glioblastoma","volume":"134","author":"Wirsching HG","year":"2016","unstructured":"Wirsching HG, Galanis E, Weller M. Glioblastoma. Handb Clin Neurol. 2016;134:381\u201397.","journal-title":"Handb Clin Neurol"},{"issue":"17","key":"e_1_3_2_300_2","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1001\/jama.2013.280319","article-title":"Glioblastoma and other malignant gliomas: a clinical review","volume":"310","author":"Omuro A","year":"2013","unstructured":"Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: a clinical review. JAMA. 2013;310((17)):1842\u201350.","journal-title":"JAMA"},{"issue":"29","key":"e_1_3_2_301_2","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202301835","article-title":"Neutrophil\u2010Mediated Tumor\u2010Targeting Delivery System of Oncolytic Bacteria Combined with ICB for Melanoma Lung Metastasis Therapy","volume":"10","author":"Liu L","year":"2023","unstructured":"Liu L, Xin W, Li Q, Huang B, Yin T, Hua S, et\u00a0al. Neutrophil\u2010Mediated Tumor\u2010Targeting Delivery System of Oncolytic Bacteria Combined with ICB for Melanoma Lung Metastasis Therapy. Adv Sci (Weinh). 2023;10((29)):e2301835.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"e_1_3_2_302_2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12951-023-01831-4","article-title":"Highly specific neutrophil\u2010mediated delivery of albumin nanoparticles to ectopic lesion for endometriosis therapy","volume":"21","author":"Zhu S","year":"2023","unstructured":"Zhu S, Zhang J, Xue N, Zhu X, Li F, Dai Q, et\u00a0al. Highly specific neutrophil\u2010mediated delivery of albumin nanoparticles to ectopic lesion for endometriosis therapy. J Nanobiotechnology. 2023;21((1)):81.","journal-title":"J Nanobiotechnology"},{"key":"e_1_3_2_303_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-022-00546-2"},{"key":"e_1_3_2_304_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-022-00965-1"},{"issue":"6","key":"e_1_3_2_305_2","doi-asserted-by":"crossref","first-page":"L435","DOI":"10.1152\/ajplung.00234.2013","article-title":"Silencing Bruton's tyrosine kinase in alveolar neutrophils protects mice from LPS\/immune complex\u2010induced acute lung injury","volume":"307","author":"Krupa A","year":"2014","unstructured":"Krupa A, Fol M, Rahman M, Stokes KY, Florence JM, Leskov IL, et\u00a0al. Silencing Bruton's tyrosine kinase in alveolar neutrophils protects mice from LPS\/immune complex\u2010induced acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2014;307((6)):L435\u201348.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"e_1_3_2_306_2","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.3389\/fimmu.2018.01827","article-title":"Chemical Tools for Targeted Amplification of Reactive Oxygen Species in Neutrophils","volume":"9","author":"Reshetnikov V","year":"2018","unstructured":"Reshetnikov V, Hahn J, Maueroder C, Czegley C, Munoz LE, Herrmann M, et\u00a0al. Chemical Tools for Targeted Amplification of Reactive Oxygen Species in Neutrophils. Front Immunol. 2018;9:1827.","journal-title":"Front Immunol"},{"key":"e_1_3_2_307_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701803"},{"issue":"5","key":"e_1_3_2_308_2","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175031","article-title":"Neutrophil extracellular traps induced by chemotherapy inhibit tumor growth in murine models of colorectal cancer","volume":"134","author":"Li Y","year":"2024","unstructured":"Li Y, Wu S, Zhao Y, Dinh T, Jiang D, Selfridge JE, et\u00a0al. Neutrophil extracellular traps induced by chemotherapy inhibit tumor growth in murine models of colorectal cancer. J Clin Invest. 2024;134((5)):e175031.","journal-title":"J Clin Invest"}],"container-title":["Cancer Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1002\/cac2.70027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T08:45:29Z","timestamp":1773823529000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1002\/cac2.70027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":307,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1002\/cac2.70027"],"URL":"https:\/\/doi.org\/10.1002\/cac2.70027","relation":{},"ISSN":["2523-3548"],"issn-type":[{"value":"2523-3548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"2024-09-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}